XML 34 R23.htm IDEA: XBRL DOCUMENT v3.22.4
STOCK COMPENSATION (Tables)
 9 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of share-based compensation expense
                 
   Three Months
Ended
December 31,
2022		   Three Months
Ended
December 31,
2021		   Nine Months
Ended
December 31,
2022		   Nine Months
Ended
December 31,
2021		 
Vesting of stock options and restricted stock units  $262,613   $201,019   $791,588   $522,234 
Total stock-based compensation expense  $262,613   $201,019   $791,588   $522,234 
                     
Weighted average number of common shares outstanding – basic and diluted   22,946,483    15,397,418    19,741,451    14,543,787 
                     
Basic and diluted loss per common share attributable to stock-based compensation expense  $(0.01)  $(0.01)  $(0.04)  $(0.04)
Options outstanding that have vested and are expected to vest
             
   Number of
Shares		   Weighted
Average
Exercise
Price		   Weighted
Average
Remaining
Contractual
Term in
Years		 
Vested   501,985   $2.83    7.83 
Expected to vest   1,201,848   $2.03    8.21 
Total   1,703,833           
Schedule of stock option activity
             
   Amount   Range of
Exercise Price		  Weighted
Average
Exercise
Price		 
Stock options outstanding at March 31, 2022   1,665,948   $1.28 - 142.50   $2.31 
Exercised   –   $–   $– 
Granted   61,600   $1.21   $1.21 
Cancelled/Expired   (23,715)  $1.41 - 57   $2.85 
Stock options outstanding at December 31, 2022   1,703,833   $1.21 - 142.50   $2.26 
Stock options exercisable at December 31, 2022   501,985   $1.28 - 142.50   $2.83